SUN-LB030 Empagliflozin Causing Euglycemic Diabetic Ketoacidosis

Background: Empagliflozin is a sodium glucose co-transporter 2 (SGLT-2) inhibitor that works in the proximal renal tubules reducing resorption of glucose and increasing urinary glucose excretion. It effectively lowers glycated hemoglobin (HbA1C) values and reduces risks of adverse cardiovascular eve...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Endocr Soc
Main Authors: Thomas, Mathew, Tran, Ly, White, Christopher, Deppe, John, Davidson, James
Format: Artigo
Jezik:Inglês
Izdano: Endocrine Society 2019
Teme:
Diabetes Mellitus and Glucose Metabolism
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6552746/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-LB030
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki